Complete laparoscopic pelvic peritonectomy plus hyperthermic intraperitoneal chemotherapy

[1]  J. Briceño-Delgado,et al.  Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis , 2020, Surgical Endoscopy.

[2]  J. Sánchez-Hidalgo,et al.  Peritoneal carcinomatosis from ovarian carcinoma treated by interval laparoscopic complete cytoreduction and HIPEC with extraction through natural orifice. , 2019, Surgical oncology.

[3]  J. Briceño-Delgado,et al.  Colorectal peritoneal metastases: Optimal management review , 2019, World journal of gastroenterology.

[4]  Jae-Weon Kim,et al.  A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms , 2019, The New England journal of medicine.

[5]  M. Pocard,et al.  A UNICANCER phase III trial of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Carcinomatosis. PRODIGE 7. , 2019, European Journal of Surgical Oncology.

[6]  Lynette M. Smith,et al.  Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures , 2019, JAMA network open.

[7]  J. Esquivel,et al.  A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis , 2018, Surgical Endoscopy.

[8]  M. Pocard,et al.  A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. , 2018, Journal of Clinical Oncology.

[9]  J. Briceño-Delgado,et al.  Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience , 2018, World Journal of Surgery.

[10]  F. Ghezzi,et al.  Laparoscopic Management of Ovarian Cancer Patients With Localized Carcinomatosis and Lymph Node Metastases: Results of a Retrospective Multi-institutional Series. , 2016, Journal of minimally invasive gynecology.

[11]  T. Chua,et al.  The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery , 2014, Journal of surgical oncology.

[12]  E. Cotte,et al.  Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  T. Chua,et al.  Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Limited Peritoneal Surface Malignancies: Feasibility, Morbidity and Outcome in an Early Experience , 2011, Annals of surgery.

[14]  T. Chua,et al.  Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?: A Systematic Review of Morbidity and Mortality , 2009, Annals of surgery.